Headline News about Rxsight Inc
![](https://images.pexels.com/photos/5849595/pexels-photo-5849595.jpeg?auto=compress&cs=tinysrgb&dpr=1&w=500)
![](https://cdn.benzinga.com/files/images/story/2024/05/09/eye-5248678.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
What 10 Analyst Ratings Have To Say About RxSight
May 07, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Assessing RxSight: Insights From 8 Financial Analysts
April 11, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Forecasting The Future: 9 Analyst Projections For RxSight
February 29, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Recap: RxSight Q4 Earnings
February 28, 2024
Via Benzinga
![](/next-assets/images/schema-image-default.png)
RxSight's Earnings Outlook
February 27, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Stifel Maintains Buy Rating for RxSight: Here's What You Need To Know
February 12, 2024
Via Benzinga
![](https://barchart-news-media-prod.aws.barchart.com/EXCLSV/ff85a6d3a357c42de45667e9e0165e0b/u4vemp3h7kssgv1k.png)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
The Analyst Landscape: 8 Takes On RxSight
January 29, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Breaking Down RxSight: 5 Analysts Share Their Views
January 08, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/01/25/jim-cramer2.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/10/stocks-to-buy-greedy1600-1024x576.png)
![](https://cdn.benzinga.com/files/images/story/2024/01/08/image_1.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Analyst Expectations for RxSight's Future
December 13, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
RxSight: Q3 Earnings Insights
November 09, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Where RxSight Stands With Analysts
August 08, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 08, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
RxSight's Earnings: A Preview
August 04, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/07/12/rxst.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for RxSight
July 12, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Analyst Expectations for RxSight's Future
April 13, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/roce_image_510.jpeg?width=1200&height=800&fit=crop)
Looking Into RxSight's Return On Capital Employed
March 09, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_5866.png?width=1200&height=800&fit=crop)
5 Analysts Have This to Say About RxSight
March 07, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Earnings Preview: RxSight
March 03, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.